Detection of metastatic head and neck squamous cell carcinoma using the relative expression of tissue-specific mir-205

Translational Oncology

Volumn 1, Issue 4, 2008, Pages 202-208

  Fletcher, Aaron M ^a   Heaford, Andrew C ^a   Trask, Douglas K ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 67650681094     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.08163     Document Type: Article

References (49)

1. Takes RP (2004). Staging of the neck in patients with head and neck squamouscell cancer: imaging techniques and biomarkers. Oral Oncol 40, 656-667.
2. Shah JP (1990). Patterns of cervical lymph node metastasis from squamous carcinomasof the upper aerodigestive tract. Am J Surg 160, 405-409.
3. Rhee D, Wenig BM, and Smith RV (2002). The significance of immunohistochemicallydemonstrated nodal micrometastases in patients with squamous cellcarcinoma of the head and neck. Laryngoscope 112, 1970-1974.
4. Thomsen JB, Christensen RK, Sorensen JA, and Krogdahl A (2007). Sentinellymph nodes in cancer of the oral cavity: is central step-sectioning enough? JOral Pathol Med 36, 425-429.
5. Greenberg JS, El Naggar AK, Mo V, Roberts D, and Myers JN (2003). Disparityin pathologic and clinical lymph node staging in oral tongue carcinoma. Implicationfor therapeutic decision making. Cancer 98, 508-515.
6. Ferlito A, Partridge M, Brennan J, and Hamakawa H (2001). Lymph node micrometastasesin head and neck cancer: a review. Acta Otolaryngol 121, 660-665.
7. Hamakawa H, Takemura K, Sumida T, Kayahara H, Tanioka H, and Sogawa K (2000). Histological study on pN upgrading of oral cancer. Virchows Arch 437,116-121.
8. Ku NN (1999). Pathologic examination of sentinel lymph nodes in breast cancer. Surg Oncol Clin N Am 8, 469-479.
9. Barrera JE, Miller ME, Said S, Jafek BW, Campana JP, and Shroyer KR (2003).Detection of occult cervical micrometastases in patients with head and necksquamous cell cancer. Laryngoscope 113, 892-896.
10. Becker MT, Shores CG, Yu KK, and Yarbrough WG (2004). Molecular assay todetect metastatic head and neck squamous cell carcinoma. Arch OtolaryngolHead Neck Surg 130, 21-27.
11. Ferris RL, Xi L, Raja S, Hunt JL, Wang J, Gooding WE, Kelly L, Ching J, Luketich JD, and Godfrey TE (2005). Molecular staging of cervical lymphnodes in squamous cell carcinoma of the head and neck. Cancer Res 65,2147-2156.
12. Mitas M, Cole DJ, Hoover L, Fraig MM, Mikhitarian K, Block MI, Hoffman BJ, Hawes RH, Gillanders WE, and Wallace MB (2003). Real-time reversetranscription-PCR detects KS1/4 mRNA in mediastinal lymph nodes from patientswith non-small cell lung cancer. Clin Chem 49, 312-315.
13. Nieuwenhuis EJ, Jaspars LH, Castelijns JA, Bakker B, Wishaupt RG, Denkers F, Leemans CR, Snow GB, and Brakenhoff RH (2003). Quantitative moleculardetection of minimal residual head and neck cancer in lymph node aspirates. Clin Cancer Res 9, 755-761.
14. Mitas M, Mikhitarian K, Walters C, Baron PL, Elliott BM, Brothers TE, Robison JG, Metcalf JS, Palesch YY, Zhang Z, et al. (2001). Quantitative realtimeRT-PCR detection of breast cancer micrometastasis using a multigenemarker panel. Int J Cancer 93, 162-171.
15. Xi L, Luketich JD, Raja S, Gooding WE, Litle VR, Coello MC, Finkelstein SD, Chestney ML, Landreneau RJ, Hughes SJ, et al. (2005). Molecular staging oflymph nodes from patients with esophageal adenocarcinoma. Clin Cancer Res 11, 1099-1109.
16. Kwon SY, Kim HJ, Woo JS, Jung KY, and Kim I (2004). The usefulness ofcytokeratin immunohistochemistry in detection of lymph node micrometastasisin neck dissection specimens. Otolaryngol Head Neck Surg 131, 300-306.
17. Marley JJ, Robinson PA, and Hume WJ (1994). Expression of human cytokeratin14 in normal, premalignant and malignant oral tissue following isolation byplaque differential hybridisation. Eur J Cancer 30B, 305-311.
18. Yamamichi N, Inada K, Ichinose M, Yamamichi-Nishina M, Mizutani T, Watanabe H, Shiogama K, Fujishiro M, Okazaki T, Yahagi N, et al. (2007).Frequent loss of Brm expression in gastric cancer correlates with histologic featuresand differentiation state. Cancer Res 67, 10727-10735.
19. Xi L, Coello MC, Litle VR, Raja S, Gooding WE, Yousem SA, El-Hefnawy T, Landreneau RJ, Luketich JD, and Godfrey TE (2006). A combination of molecularmarkers accurately detects lymph node metastasis in non-small cell lungcancer patients. Clin Cancer Res 12, 2484-2491.
20. Chen G, McIver CM, Texler M, Lloyd JM, Rieger N, Hewett PJ, Sen Wan D, and Hardingham JE (2004). Detection of occult metastasis in lymph nodes from colorectalcancer patients: a multiple-marker reverse transcriptase-polymerase chainreaction study. Dis Colon Rectum 47, 679-686.
21. Saglam O, Shah V, and Worsham MJ (2007). Molecular differentiation of earlyand late stage laryngeal squamous cell carcinoma: an exploratory analysis. DiagnMol Pathol 16, 218-221.
22. Ramaswamy S, Tamayo P, Rifkin R, Mukherjee S, Yeang CH, Angelo M, Ladd C, Reich M, Latulippe E, Mesirov JP, et al. (2001).Multiclass cancer diagnosis usingtumor gene expression signatures. Proc Natl Acad Sci USA 98, 15149-15154.
23. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, and Johnson JM (2005). Microarray analysis shows that somemicroRNAs downregulate large numbers of target mRNAs. Nature 433, 769-773.
24. Sood P, Krek A, Zavolan M, Macino G, and Rajewsky N (2006). Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl AcadSci USA 103, 2746-2751.
25. Liang Y, Ridzon D, Wong L, and Chen C (2007). Characterization of microRNAexpression profiles in normal human tissues. BMC Genomics 8, 166.
26. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, et al. (2005). MicroRNA expression profilesclassify human cancers. Nature 435, 834-838.
27. Rosenfeld N, Aharonov R, Meiri E, Rosenwald S, Spector Y, Zepeniuk M, Benjamin H, Shabes N, Tabak S, Levy A, et al. (2008). MicroRNAs accuratelyidentify cancer tissue origin. Nat Biotechnol 26, 462-469.
28. Nikiforova MN, Tseng GC, Steward D, Diorio D, and Nikiforov YE (2008).MicroRNA expression profiling of thyroid tumors: biological significance anddiagnostic utility. J Clin Endocrinol Metab 93, 1600-1608. Translational Oncology Vol. 1, No. 4, 2008 Mir-205 in Detecting Metastatic HNSCC Fletcher et al. 207
29. Xi Y, Nakajima G, Gavin E, Morris CG, Kudo K, Hayashi K, and Ju J (2007).Systematic analysis of microRNA expression of RNA extracted from fresh frozenand formalin-fixed paraffin-embedded samples. RNA 13, 1668-1674.
30. Doleshal M, Magotra AA, Choudhury B, Cannon BD, Labourier E, and Szafranska AE (2008). Evaluation and validation of total RNA extraction methods for micro-RNA expression analyses in formalin-fixed, paraffin-embedded tissues. JMol Diagn 10, 203-211.
31. Li J, Smyth P, Flavin R, Cahill S, Denning K, Aherne S, Guenther SM, O'Leary JJ, and Sheils O (2007). Comparison of miRNA expression patterns using totalRNA extracted from matched samples of formalin-fixed paraffin-embedded(FFPE) cells and snap frozen cells. BMC Biotechnol 7, 36.
32. Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, and Mourelatos Z (2004). Microarray-based, high-throughput gene expression profiling of micro-RNAs. Nat Methods 1, 155-161.
33. Tran N, McLean T, Zhang X, Zhao CJ, Thomson JM, O'Brien C, and Rose B (2007). MicroRNA expression profiles in head and neck cancer cell lines. BiochemBiophys Res Commun 358, 12-17.
34. Feber A, Xi L, Luketich JD, Pennathur A, Landreneau RJ, Wu M, Swanson SJ, Godfrey TE, and Litle VR (2008). MicroRNA expression profiles of esophagealcancer. J Thorac Cardiovasc Surg 135, 255-260; discussion 260.
35. Gottardo F, Liu CG, Ferracin M, Calin GA, Fassan M, Bassi P, Sevignani C, Byrne D, Negrini M, Pagano F, et al. (2007). Micro-RNA profiling in kidneyand bladder cancers. Urol Oncol 25, 387-392.
36. Ryan DG, Oliveira-Fernandes M, and Lavker RM (2006). MicroRNAs of themammalian eye display distinct and overlapping tissue specificity. Mol Vis 12,1175-1184.
37. Jiang J, Lee EJ, Gusev Y, and Schmittgen TD (2005). Real-time expression profilingof microRNA precursors in human cancer cell lines. Nucleic Acids Res 33,5394-5403.
38. Kang MK, Guo W, and Park NH (1998). Replicative senescence of normal humanoral keratinocytes is associated with the loss of telomerase activity withoutshortening of telomeres. Cell Growth Differ 9, 85-95.
39. Livak KJ and Schmittgen TD (2001). Analysis of relative gene expression datausing real-time quantitative PCR and the 2(Delta Delta C(T)) method. Methods 25, 402-408.
40. Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, Barbosa-Morais NL, Teschendorff AE, Green AR, Ellis IO, et al. (2007). MicroRNAexpression profiling of human breast cancer identifies new markers of tumorsubtype. Genome Biol 8, R214.
41. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, Schwartz G, Wells W, Kauppinen S, and Cole CN (2007). Altered microRNA expressionconfined to specific epithelial cell subpopulations in breast cancer. Cancer Res 67, 11612-11620.
42. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, Goodman SN, and Sidransky D (1995). Molecular assessment of histopathological staging insquamous-cell carcinoma of the head and neck. N Engl J Med 332, 429-435.
43. Wadsworth JT, Somers KD, Stack BC Jr, Cazares L, Malik G, Adam BL, Wright GL Jr, and Semmes OJ (2004). Identification of patients with head and neck cancerusing serum protein profiles. Arch Otolaryngol Head Neck Surg 130, 98-104.
44. Hornstein E, Mansfield JH, Yekta S, Hu JK, Harfe BD, McManus MT, Baskerville S, Bartel DP, and Tabin CJ (2005). The microRNA miR-196 acts upstream ofHoxb8 and Shh in limb development. Nature 438, 671-674.
45. Sempere LF, Freemantle S, Pitha-Rowe I, Moss E, Dmitrovsky E, and Ambros V (2004). Expression profiling of mammalian microRNAs uncovers a subset ofbrain-expressed microRNAs with possible roles in murine and human neuronaldifferentiation. Genome Biol 5, R13.
46. Lee YS, Kim HK, Chung S, Kim KS, and Dutta A (2005). Depletion of humanmicro-RNA miR-125b reveals that it is critical for the proliferation of differentiatedcells but not for the down-regulation of putative targets during differentiation. J Biol Chem 280, 16635-16641.
47. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, and Wei WI (2008). MaturemiR-184 as potential oncogenic microRNA of squamous cell carcinoma oftongue. Clin Cancer Res 14, 2588-2592.
48. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, Yuen ST, Chan TL, Kwong DL, Au GK, et al. (2008). MicroRNA expression profilesassociated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 299, 425-436.
49. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198.